Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya L Cyr

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Reviews in Allergy & Immunology|January 27, 2026
Atopic Comorbidities and Topical Steroids in Early Childhood Atopic Dermatitis: Are We Missing a Piece of the Puzzle?Courtney A Chau, Sonya L Cyr, Ruchi Gupta, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 24, 2009
Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccineYan Huang, Sonya L Cyr, David S Burt, et al.
Clinical Reviews in Allergy & Immunology|February 26, 2026
Correction to: Atopic Comorbidities and Topical Steroids in Early Childhood Atopic Dermatitis: Are We Missing a Piece of the Puzzle?Courtney A Chau, Sonya L Cyr, Ruchi Gupta, et al.
Vaccine|March 22, 2007
C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccineSonya L Cyr, Taff Jones, Ioana Stoica-Popescu, et al.
Dermatology and Therapy|May 21, 2022
Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic DermatitisEl-Bdaoui Haddad, Sonya L Cyr, Kazuhiko Arima, et al.
Vaccine|June 15, 2007
Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathologySonya L Cyr, Taff Jones, Ioana Stoica-Popescu, et al.
Dermatology and Therapy|September 12, 2025
Real-World Onset of Atopic Comorbidities Relative to Atopic Dermatitis in Pediatric PatientsYael A Leshem, Clara Weil, William W Busse, et al.
Vaccine|November 18, 2008
TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge modelSonya L Cyr, Isabelle Angers, Loic Guillot, et al.
Frontiers in Immunology|June 22, 2026
Restoring balance in atopic disorders: insights into type 2 immunity and chronic inflammationEric L Simpson, Oscar Palomares, Brian S Kim, et al.
Vaccine|August 19, 2003
A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunityTaff Jones, Francine Allard, Sonya L Cyr, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Reviews in Allergy & Immunology|January 27, 2026
Atopic Comorbidities and Topical Steroids in Early Childhood Atopic Dermatitis: Are We Missing a Piece of the Puzzle?Courtney A Chau, Sonya L Cyr, Ruchi Gupta, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 24, 2009
Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccineYan Huang, Sonya L Cyr, David S Burt, et al.
Clinical Reviews in Allergy & Immunology|February 26, 2026
Correction to: Atopic Comorbidities and Topical Steroids in Early Childhood Atopic Dermatitis: Are We Missing a Piece of the Puzzle?Courtney A Chau, Sonya L Cyr, Ruchi Gupta, et al.
Vaccine|March 22, 2007
C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccineSonya L Cyr, Taff Jones, Ioana Stoica-Popescu, et al.
Dermatology and Therapy|May 21, 2022
Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic DermatitisEl-Bdaoui Haddad, Sonya L Cyr, Kazuhiko Arima, et al.
Vaccine|June 15, 2007
Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathologySonya L Cyr, Taff Jones, Ioana Stoica-Popescu, et al.
Dermatology and Therapy|September 12, 2025
Real-World Onset of Atopic Comorbidities Relative to Atopic Dermatitis in Pediatric PatientsYael A Leshem, Clara Weil, William W Busse, et al.
Vaccine|November 18, 2008
TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge modelSonya L Cyr, Isabelle Angers, Loic Guillot, et al.
Frontiers in Immunology|June 22, 2026
Restoring balance in atopic disorders: insights into type 2 immunity and chronic inflammationEric L Simpson, Oscar Palomares, Brian S Kim, et al.
Vaccine|August 19, 2003
A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunityTaff Jones, Francine Allard, Sonya L Cyr, et al.
Pageof 3